跳转至内容
Merck
CN

PHR1025

乳糖(无水)

Pharmaceutical Secondary Standard; Certified Reference Material

别名:

乳糖

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C12H22O11
化学文摘社编号:
分子量:
342.30
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
EC Number:
200-559-2
Beilstein/REAXYS Number:
93796
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

乳糖(无水), Pharmaceutical Secondary Standard; Certified Reference Material

InChI

1S/C12H22O11/c13-1-4(16)7(18)11(5(17)2-14)23-12-10(21)9(20)8(19)6(3-15)22-12/h1,4-12,14-21H,2-3H2/t4-,5+,6+,7+,8-,9-,10+,11+,12-/m0/s1

InChI key

DKXNBNKWCZZMJT-JVCRWLNRSA-N

SMILES string

OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C=O

grade

certified reference material
pharmaceutical secondary standard

agency

traceable to Ph. Eur. A1206000
traceable to USP 1356676

API family

lactose

CofA

current certificate can be downloaded

analyte chemical class(es)

oligosaccharides

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

application(s)

cleaning products
cosmetics
food and beverages
personal care
pharmaceutical (small molecule)

format

neat

storage temp.

2-30°C

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

无水乳糖可用作药物参考标准品,通过色谱技术测定药物制剂中的分析物。
这些二级标准品是经过检验的认证标准物质(CRM)。它们适用于多种分析应用,包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。

General description

用于质量控制的制药二级标准,为制药实验室和制造商提供了一种方便且具有成本效益的替代方案,可用于制定内部工作标准品。

Other Notes

若要查看此材料的分析证书示例,请在下面的区域中输入 LRAB2931。这只是一个示例证书,可能与您收到批次的产品无关。
该认证参考物质(CRM)根据ISO 17034ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在分析证书上找到。

Analysis Note

These secondary standards offer multi-traceability to the USP and EP (PhEur) primary standards, where they are available.

存储类别

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Assessment of feasibility of Maillard reaction between baclofen and lactose by liquid chromatography and tandem mass spectrometry, application to pre formulation studies
Monajjemzadeh F, et al.
Aaps Pharmscitech, 10(2), 649-659 (2009)
Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets
Monajjemzadeh F, et al.
European Journal of Pharmaceutics and Biopharmaceutics, 73(3), 404-413 (2009)
The influence of carrier and drug morphology on drug delivery from dry powder formulations
Larhrib H, et al.
International Journal of Pharmaceutics, 257(1-2), 283-296 (2003)
Filipa Mendes et al.
Applied and environmental microbiology, 79(19), 5949-5961 (2013-07-23)
Mixed populations of Saccharomyces cerevisiae yeasts and lactic acid bacteria occur in many dairy, food, and beverage fermentations, but knowledge about their interactions is incomplete. In the present study, interactions between Saccharomyces cerevisiae and Lactobacillus delbrueckii subsp. bulgaricus, two microorganisms
R H de Roest et al.
International journal of clinical practice, 67(9), 895-903 (2013-05-25)
Current treatment for irritable bowel syndrome (IBS) is suboptimal. Fermentable oligo-, di-, mono-saccharides and polyols (FODMAPs) may trigger gastrointestinal symptoms in IBS patients. Our aim was to determine whether a low FODMAP diet improves symptoms in IBS patients. Irritable bowel

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持